List of Tables
Table 1. Global Meningococcal Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Meningococcal Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Meningococcal Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Meningococcal Vaccine Sales (10K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Meningococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Meningococcal Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Meningococcal Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Meningococcal Vaccine Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Meningococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Meningococcal Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meningococcal Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Meningococcal Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meningococcal Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Meningococcal Vaccine Sales by Region (2019-2024) & (10K Pcs)
Table 18. Global Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Meningococcal Vaccine Sales by Region (2025-2030) & (10K Pcs)
Table 20. Global Meningococcal Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Meningococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Meningococcal Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Meningococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Meningococcal Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
Table 27. North America Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)
Table 28. North America Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
Table 32. Europe Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)
Table 33. Europe Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Meningococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Meningococcal Vaccine Sales by Region (2019-2024) & (10K Pcs)
Table 37. Asia Pacific Meningococcal Vaccine Sales by Region (2025-2030) & (10K Pcs)
Table 38. Asia Pacific Meningococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Meningococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
Table 42. Latin America Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)
Table 43. Latin America Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
Table 47. Middle East & Africa Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)
Table 48. Middle East & Africa Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Meningococcal Vaccine Sales (10K Pcs) by Type (2019-2024)
Table 51. Global Meningococcal Vaccine Sales (10K Pcs) by Type (2025-2030)
Table 52. Global Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Meningococcal Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Meningococcal Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Meningococcal Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Meningococcal Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Meningococcal Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Meningococcal Vaccine Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Meningococcal Vaccine Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Meningococcal Vaccine Sales (10K Pcs) by Application (2019-2024)
Table 61. Global Meningococcal Vaccine Sales (10K Pcs) by Application (2025-2030)
Table 62. Global Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Meningococcal Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Meningococcal Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Meningococcal Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Meningococcal Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Meningococcal Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Meningococcal Vaccine Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Meningococcal Vaccine Price (USD/Pcs) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Novartis Meningococcal Vaccine Product
Table 74. Novartis Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. GSK Meningococcal Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Merck Meningococcal Vaccine Product
Table 84. Merck Recent Developments/Updates
Table 85. CSL Corporation Information
Table 86. CSL Description and Business Overview
Table 87. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. CSL Meningococcal Vaccine Product
Table 89. CSL Recent Developments/Updates
Table 90. Baxter Corporation Information
Table 91. Baxter Description and Business Overview
Table 92. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Baxter Meningococcal Vaccine Product
Table 94. Baxter Recent Developments/Updates
Table 95. JN International Medical Corporation Corporation Information
Table 96. JN International Medical Corporation Description and Business Overview
Table 97. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. JN International Medical Corporation Meningococcal Vaccine Product
Table 99. JN International Medical Corporation Recent Developments/Updates
Table 100. Serum Institute of India Corporation Information
Table 101. Serum Institute of India Description and Business Overview
Table 102. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Serum Institute of India Meningococcal Vaccine Product
Table 104. Serum Institute of India Recent Developments/Updates
Table 105. Bio-Med Corporation Information
Table 106. Bio-Med Description and Business Overview
Table 107. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Bio-Med Meningococcal Vaccine Product
Table 109. Bio-Med Recent Developments/Updates
Table 110. China National Biotec Group Corporation Information
Table 111. China National Biotec Group Description and Business Overview
Table 112. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. China National Biotec Group Meningococcal Vaccine Product
Table 114. China National Biotec Group Recent Developments/Updates
Table 115. Hualan Bio Corporation Information
Table 116. Hualan Bio Description and Business Overview
Table 117. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Hualan Bio Meningococcal Vaccine Product
Table 119. Hualan Bio Recent Developments/Updates
Table 120. Walvax Corporation Information
Table 121. Walvax Description and Business Overview
Table 122. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Walvax Meningococcal Vaccine Product
Table 124. Walvax Recent Developments/Updates
Table 125. Zhifei Corporation Information
Table 126. Zhifei Description and Business Overview
Table 127. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 128. Zhifei Meningococcal Vaccine Product
Table 129. Zhifei Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Meningococcal Vaccine Distributors List
Table 133. Meningococcal Vaccine Customers List
Table 134. Meningococcal Vaccine Market Trends
Table 135. Meningococcal Vaccine Market Drivers
Table 136. Meningococcal Vaccine Market Challenges
Table 137. Meningococcal Vaccine Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Meningococcal Vaccine
Figure 2. Global Meningococcal Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Meningococcal Vaccine Market Share by Type in 2023 & 2030
Figure 4. Meningtits A Product Picture
Figure 5. Polysaccharide Meningtitis AC Product Picture
Figure 6. Meningitis ACYW Product Picture
Figure 7. Global Meningococcal Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Meningococcal Vaccine Market Share by Application in 2023 & 2030
Figure 9. 6 Months-15Year
Figure 10. over 3 Year
Figure 11. over 2 Year
Figure 12. over 3 Months
Figure 13. Global Meningococcal Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Meningococcal Vaccine Market Size (2019-2030) & (US$ Million)
Figure 15. Global Meningococcal Vaccine Sales (2019-2030) & (10K Pcs)
Figure 16. Global Meningococcal Vaccine Average Price (USD/Pcs) & (2019-2030)
Figure 17. Meningococcal Vaccine Report Years Considered
Figure 18. Meningococcal Vaccine Sales Share by Manufacturers in 2023
Figure 19. Global Meningococcal Vaccine Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Meningococcal Vaccine Players: Market Share by Revenue in 2023
Figure 21. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Meningococcal Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Meningococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 24. North America Meningococcal Vaccine Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Meningococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 28. Europe Meningococcal Vaccine Revenue Market Share by Country (2019-2030)
Figure 29. Germany Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Meningococcal Vaccine Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region (2019-2030)
Figure 36. China Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Meningococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Latin America Meningococcal Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Meningococcal Vaccine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Meningococcal Vaccine by Type (2019-2030)
Figure 57. Global Meningococcal Vaccine Price (USD/Pcs) by Type (2019-2030)
Figure 58. Global Sales Market Share of Meningococcal Vaccine by Application (2019-2030)
Figure 59. Global Revenue Market Share of Meningococcal Vaccine by Application (2019-2030)
Figure 60. Global Meningococcal Vaccine Price (USD/Pcs) by Application (2019-2030)
Figure 61. Meningococcal Vaccine Value Chain
Figure 62. Meningococcal Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed